Thomas Schubert is a dedicated professional with nearly 15 years of experience in biophysics, currently serving as the Head of Operations in Biotechnology at Helmholtz Munich. Their journey in the field began with a comprehensive education at the University of Regensburg, where they earned a Diploma in Biology, followed by a PhD focused on Epigenetics. Thomas has held various roles, including CEO of 2bind, a contract research organization that has completed over 1700 research projects. They are passionate about advancing technologies in healthcare, particularly through their work on transforming histopathology from 2D to 3D diagnostics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices